Microfluidics Market By Application (Medical/Healthcare, Non-Medical) , By Material (Silicone, Glass, Polymer, PDMS, Others) By Technology (Lab-On-A-Chip, Organs-On-Chips, Continuous Flow Microfluidics, Optofluidics & Microfluidics, Acoustofluidics & Micr

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,425	320 Pages	Allied Market Research	August, 2024	ALMR19510166

Best Price Guarantee
Price	from $4,425
Length	320 Pages
Publisher	Allied Market Research
Published Date	August, 2024
SKU	ALMR19510166

Microfluidics Market By Application (Medical/Healthcare, Non-Medical) , By Material (Silicone, Glass, Polymer, PDMS, Others) By Technology (Lab-On-A-Chip, Organs-On-Chips, Continuous Flow Microfluidics, Optofluidics & Microfluidics, Acoustofluidics & Microfluidics, Electrophoresis & Microfluidics) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Microfluidics Market Expected to Garner $77.5 Billion by 2033, Growing at a CAGR of 13.7%

The global microfluidics market is expected to grow primarily due to the growing demand for point-of-care diagnostics and adoption in biomedical research, diagnostics, & drug delivery. The Asia-Pacific region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global microfluidics market was valued at $23.2 billion in 2023 and is expected to register a revenue of $77.5 billion by 2033 at a CAGR of 13.7% during the forecast period 2024-2033.

Dynamics of the Market

The increasing need for point of care diagnostics and the rising adoption in biomedical research, diagnostics, & drug delivery are expected to make the microfluidics market a highly profitable one in the forecast period. Besides, the growth in the wearable device industry is expected to drive market growth.
However, according to market analysts, the stringent regulatory requirements and the high initial costs associated with microfluidic devices might restrain the growth of the market.
Advanced technologies for microfluidic system design & manufacturing and the development of new products & device miniaturization are predicted to offer numerous growth opportunities for the microfluidics market in the forecast period. Moreover, the growing utilization of 3D printing technologies for rapid prototyping & customization of microfluidic devices is expected to boost the market forward in the coming years.

Key Players of the Market

The major players of the microfluidics market include Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Standard BioTools, Abbott, and Danaher Corporation.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Key Market Segments

By Application

Medical/Healthcare
Non-Medical

By Material

Silicone
Glass
Polymer
PDMS
Others

By Technology

Lab-On-A-Chip
Organs-On-Chips
Continuous Flow Microfluidics
Optofluidics Microfluidics
Acoustofluidics Microfluidics
Electrophoresis Microfluidics

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
UAE
Rest of LAMEA

Key Market Players

Illumina, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Standard BioTools
Danaher Corporation
Abbott
bioMerieux

CHAPTER 1: INTRODUCTION: 1.1. Report Description; 1.2. Key Market Segments; 1.3. Key Benefits; 1.4. Research Methodology; 1.4.1. Primary Research; 1.4.2. Secondary Research; 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY: 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE: 3.1. Market Definition and Scope; 3.2. Key Findings; 3.2.1. Top Investment Pockets; 3.2.2. Top Winning Strategies; 3.3. Porter's Five Forces Analysis; 3.3.1. Bargaining Power of Suppliers; 3.3.2. Threat of New Entrants; 3.3.3. Threat of Substitutes; 3.3.4. Competitive Rivalry; 3.3.5. Bargaining Power among Buyers; 3.4. Market Dynamics; 3.4.1. Drivers; 3.4.2. Restraints; 3.4.3. Opportunities
CHAPTER 4: MICROFLUIDICS MARKET, BY APPLICATION: 4.1. Market Overview; 4.1.1 Market Size and Forecast, By Application; 4.2. Medical/Healthcare; 4.2.1. Key Market Trends, Growth Factors and Opportunities; 4.2.2. Market Size and Forecast, By Region; 4.2.3. Market Share Analysis, By Country; 4.3. Non-Medical; 4.3.1. Key Market Trends, Growth Factors and Opportunities; 4.3.2. Market Size and Forecast, By Region; 4.3.3. Market Share Analysis, By Country
CHAPTER 5: MICROFLUIDICS MARKET, BY MATERIAL: 5.1. Market Overview; 5.1.1 Market Size and Forecast, By Material; 5.2. Silicone; 5.2.1. Key Market Trends, Growth Factors and Opportunities; 5.2.2. Market Size and Forecast, By Region; 5.2.3. Market Share Analysis, By Country; 5.3. Glass; 5.3.1. Key Market Trends, Growth Factors and Opportunities; 5.3.2. Market Size and Forecast, By Region; 5.3.3. Market Share Analysis, By Country; 5.4. Polymer; 5.4.1. Key Market Trends, Growth Factors and Opportunities; 5.4.2. Market Size and Forecast, By Region; 5.4.3. Market Share Analysis, By Country; 5.5. PDMS; 5.5.1. Key Market Trends, Growth Factors and Opportunities; 5.5.2. Market Size and Forecast, By Region; 5.5.3. Market Share Analysis, By Country; 5.6. Others; 5.6.1. Key Market Trends, Growth Factors and Opportunities; 5.6.2. Market Size and Forecast, By Region; 5.6.3. Market Share Analysis, By Country
CHAPTER 6: MICROFLUIDICS MARKET, BY TECHNOLOGY: 6.1. Market Overview; 6.1.1 Market Size and Forecast, By Technology; 6.2. Lab-On-A-Chip; 6.2.1. Key Market Trends, Growth Factors and Opportunities; 6.2.2. Market Size and Forecast, By Region; 6.2.3. Market Share Analysis, By Country; 6.3. Organs-On-Chips; 6.3.1. Key Market Trends, Growth Factors and Opportunities; 6.3.2. Market Size and Forecast, By Region; 6.3.3. Market Share Analysis, By Country; 6.4. Continuous Flow Microfluidics; 6.4.1. Key Market Trends, Growth Factors and Opportunities; 6.4.2. Market Size and Forecast, By Region; 6.4.3. Market Share Analysis, By Country; 6.5. Optofluidics Microfluidics; 6.5.1. Key Market Trends, Growth Factors and Opportunities; 6.5.2. Market Size and Forecast, By Region; 6.5.3. Market Share Analysis, By Country; 6.6. Acoustofluidics Microfluidics; 6.6.1. Key Market Trends, Growth Factors and Opportunities; 6.6.2. Market Size and Forecast, By Region; 6.6.3. Market Share Analysis, By Country; 6.7. Electrophoresis Microfluidics; 6.7.1. Key Market Trends, Growth Factors and Opportunities; 6.7.2. Market Size and Forecast, By Region; 6.7.3. Market Share Analysis, By Country
CHAPTER 7: MICROFLUIDICS MARKET, BY REGION: 7.1. Market Overview; 7.1.1 Market Size and Forecast, By Region; 7.2. North America; 7.2.1. Key Market Trends and Opportunities; 7.2.2. Market Size and Forecast, By Application; 7.2.3. Market Size and Forecast, By Material; 7.2.4. Market Size and Forecast, By Technology; 7.2.5. Market Size and Forecast, By Country; 7.2.6. U.S. Microfluidics Market; 7.2.6.1. Market Size and Forecast, By Application; 7.2.6.2. Market Size and Forecast, By Material; 7.2.6.3. Market Size and Forecast, By Technology; 7.2.7. Canada Microfluidics Market; 7.2.7.1. Market Size and Forecast, By Application; 7.2.7.2. Market Size and Forecast, By Material; 7.2.7.3. Market Size and Forecast, By Technology; 7.2.8. Mexico Microfluidics Market; 7.2.8.1. Market Size and Forecast, By Application; 7.2.8.2. Market Size and Forecast, By Material; 7.2.8.3. Market Size and Forecast, By Technology; 7.3. Europe; 7.3.1. Key Market Trends and Opportunities; 7.3.2. Market Size and Forecast, By Application; 7.3.3. Market Size and Forecast, By Material; 7.3.4. Market Size and Forecast, By Technology; 7.3.5. Market Size and Forecast, By Country; 7.3.6. France Microfluidics Market; 7.3.6.1. Market Size and Forecast, By Application; 7.3.6.2. Market Size and Forecast, By Material; 7.3.6.3. Market Size and Forecast, By Technology; 7.3.7. Germany Microfluidics Market; 7.3.7.1. Market Size and Forecast, By Application; 7.3.7.2. Market Size and Forecast, By Material; 7.3.7.3. Market Size and Forecast, By Technology; 7.3.8. Italy Microfluidics Market; 7.3.8.1. Market Size and Forecast, By Application; 7.3.8.2. Market Size and Forecast, By Material; 7.3.8.3. Market Size and Forecast, By Technology; 7.3.9. Spain Microfluidics Market; 7.3.9.1. Market Size and Forecast, By Application; 7.3.9.2. Market Size and Forecast, By Material; 7.3.9.3. Market Size and Forecast, By Technology; 7.3.10. UK Microfluidics Market; 7.3.10.1. Market Size and Forecast, By Application; 7.3.10.2. Market Size and Forecast, By Material; 7.3.10.3. Market Size and Forecast, By Technology; 7.3.11. Rest Of Europe Microfluidics Market; 7.3.11.1. Market Size and Forecast, By Application; 7.3.11.2. Market Size and Forecast, By Material; 7.3.11.3. Market Size and Forecast, By Technology; 7.4. Asia-Pacific; 7.4.1. Key Market Trends and Opportunities; 7.4.2. Market Size and Forecast, By Application; 7.4.3. Market Size and Forecast, By Material; 7.4.4. Market Size and Forecast, By Technology; 7.4.5. Market Size and Forecast, By Country; 7.4.6. China Microfluidics Market; 7.4.6.1. Market Size and Forecast, By Application; 7.4.6.2. Market Size and Forecast, By Material; 7.4.6.3. Market Size and Forecast, By Technology; 7.4.7. Japan Microfluidics Market; 7.4.7.1. Market Size and Forecast, By Application; 7.4.7.2. Market Size and Forecast, By Material; 7.4.7.3. Market Size and Forecast, By Technology; 7.4.8. India Microfluidics Market; 7.4.8.1. Market Size and Forecast, By Application; 7.4.8.2. Market Size and Forecast, By Material; 7.4.8.3. Market Size and Forecast, By Technology; 7.4.9. South Korea Microfluidics Market; 7.4.9.1. Market Size and Forecast, By Application; 7.4.9.2. Market Size and Forecast, By Material; 7.4.9.3. Market Size and Forecast, By Technology; 7.4.10. Australia Microfluidics Market; 7.4.10.1. Market Size and Forecast, By Application; 7.4.10.2. Market Size and Forecast, By Material; 7.4.10.3. Market Size and Forecast, By Technology; 7.4.11. Rest of Asia-Pacific Microfluidics Market; 7.4.11.1. Market Size and Forecast, By Application; 7.4.11.2. Market Size and Forecast, By Material; 7.4.11.3. Market Size and Forecast, By Technology; 7.5. LAMEA; 7.5.1. Key Market Trends and Opportunities; 7.5.2. Market Size and Forecast, By Application; 7.5.3. Market Size and Forecast, By Material; 7.5.4. Market Size and Forecast, By Technology; 7.5.5. Market Size and Forecast, By Country; 7.5.6. Brazil Microfluidics Market; 7.5.6.1. Market Size and Forecast, By Application; 7.5.6.2. Market Size and Forecast, By Material; 7.5.6.3. Market Size and Forecast, By Technology; 7.5.7. South Africa Microfluidics Market; 7.5.7.1. Market Size and Forecast, By Application; 7.5.7.2. Market Size and Forecast, By Material; 7.5.7.3. Market Size and Forecast, By Technology; 7.5.8. Saudi Arabia Microfluidics Market; 7.5.8.1. Market Size and Forecast, By Application; 7.5.8.2. Market Size and Forecast, By Material; 7.5.8.3. Market Size and Forecast, By Technology; 7.5.9. UAE Microfluidics Market; 7.5.9.1. Market Size and Forecast, By Application; 7.5.9.2. Market Size and Forecast, By Material; 7.5.9.3. Market Size and Forecast, By Technology; 7.5.10. Rest of LAMEA Microfluidics Market; 7.5.10.1. Market Size and Forecast, By Application; 7.5.10.2. Market Size and Forecast, By Material; 7.5.10.3. Market Size and Forecast, By Technology
CHAPTER 8: COMPETITIVE LANDSCAPE: 8.1. Introduction; 8.2. Top Winning Strategies; 8.3. Product Mapping Of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES: 9.1. Illumina, Inc.; 9.1.1. Company Overview; 9.1.2. Key Executives; 9.1.3. Company Snapshot; 9.1.4. Operating Business Segments; 9.1.5. Product Portfolio; 9.1.6. Business Performance; 9.1.7. Key Strategic Moves and Developments; 9.2. Bio-Rad Laboratories, Inc.; 9.2.1. Company Overview; 9.2.2. Key Executives; 9.2.3. Company Snapshot; 9.2.4. Operating Business Segments; 9.2.5. Product Portfolio; 9.2.6. Business Performance; 9.2.7. Key Strategic Moves and Developments; 9.3. F. Hoffmann-La Roche Ltd; 9.3.1. Company Overview; 9.3.2. Key Executives; 9.3.3. Company Snapshot; 9.3.4. Operating Business Segments; 9.3.5. Product Portfolio; 9.3.6. Business Performance; 9.3.7. Key Strategic Moves and Developments; 9.4. PerkinElmer, Inc.; 9.4.1. Company Overview; 9.4.2. Key Executives; 9.4.3. Company Snapshot; 9.4.4. Operating Business Segments; 9.4.5. Product Portfolio; 9.4.6. Business Performance; 9.4.7. Key Strategic Moves and Developments; 9.5. Thermo Fisher Scientific Inc.; 9.5.1. Company Overview; 9.5.2. Key Executives; 9.5.3. Company Snapshot; 9.5.4. Operating Business Segments; 9.5.5. Product Portfolio; 9.5.6. Business Performance; 9.5.7. Key Strategic Moves and Developments; 9.6. Agilent Technologies, Inc.; 9.6.1. Company Overview; 9.6.2. Key Executives; 9.6.3. Company Snapshot; 9.6.4. Operating Business Segments; 9.6.5. Product Portfolio; 9.6.6. Business Performance; 9.6.7. Key Strategic Moves and Developments; 9.7. Standard BioTools; 9.7.1. Company Overview; 9.7.2. Key Executives; 9.7.3. Company Snapshot; 9.7.4. Operating Business Segments; 9.7.5. Product Portfolio; 9.7.6. Business Performance; 9.7.7. Key Strategic Moves and Developments; 9.8. Danaher Corporation; 9.8.1. Company Overview; 9.8.2. Key Executives; 9.8.3. Company Snapshot; 9.8.4. Operating Business Segments; 9.8.5. Product Portfolio; 9.8.6. Business Performance; 9.8.7. Key Strategic Moves and Developments; 9.9. Abbott; 9.9.1. Company Overview; 9.9.2. Key Executives; 9.9.3. Company Snapshot; 9.9.4. Operating Business Segments; 9.9.5. Product Portfolio; 9.9.6. Business Performance; 9.9.7. Key Strategic Moves and Developments; 9.10. BioMerieux; 9.10.1. Company Overview; 9.10.2. Key Executives; 9.10.3. Company Snapshot; 9.10.4. Operating Business Segments; 9.10.5. Product Portfolio; 9.10.6. Business Performance; 9.10.7. Key Strategic Moves and Developments
LIST OF TABLES: TABLE 1. GLOBAL MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 2. MICROFLUIDICS MARKET FOR MEDICAL/HEALTHCARE, BY REGION, 2024 - 2033 ($MILLION); TABLE 3. MICROFLUIDICS MARKET FOR NON-MEDICAL, BY REGION, 2024 - 2033 ($MILLION); TABLE 4. GLOBAL MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 5. MICROFLUIDICS MARKET FOR SILICONE, BY REGION, 2024 - 2033 ($MILLION); TABLE 6. MICROFLUIDICS MARKET FOR GLASS, BY REGION, 2024 - 2033 ($MILLION); TABLE 7. MICROFLUIDICS MARKET FOR POLYMER, BY REGION, 2024 - 2033 ($MILLION); TABLE 8. MICROFLUIDICS MARKET FOR PDMS, BY REGION, 2024 - 2033 ($MILLION); TABLE 9. MICROFLUIDICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION); TABLE 10. GLOBAL MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 11. MICROFLUIDICS MARKET FOR LAB-ON-A-CHIP, BY REGION, 2024 - 2033 ($MILLION); TABLE 12. MICROFLUIDICS MARKET FOR ORGANS-ON-CHIPS, BY REGION, 2024 - 2033 ($MILLION); TABLE 13. MICROFLUIDICS MARKET FOR CONTINUOUS FLOW MICROFLUIDICS, BY REGION, 2024 - 2033 ($MILLION); TABLE 14. MICROFLUIDICS MARKET FOR OPTOFLUIDICS MICROFLUIDICS, BY REGION, 2024 - 2033 ($MILLION); TABLE 15. MICROFLUIDICS MARKET FOR ACOUSTOFLUIDICS MICROFLUIDICS, BY REGION, 2024 - 2033 ($MILLION); TABLE 16. MICROFLUIDICS MARKET FOR ELECTROPHORESIS MICROFLUIDICS, BY REGION, 2024 - 2033 ($MILLION); TABLE 17. MICROFLUIDICS MARKET, BY REGION, 2024 - 2033 ($MILLION); TABLE 18. NORTH AMERICA MICROFLUIDICS MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 19. NORTH AMERICA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 20. NORTH AMERICA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 21. NORTH AMERICA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 22. U.S. MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 23. U.S. MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 24. U.S. MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 25. CANADA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 26. CANADA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 27. CANADA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 28. MEXICO MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 29. MEXICO MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 30. MEXICO MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 31. EUROPE MICROFLUIDICS MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 32. EUROPE MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 33. EUROPE MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 34. EUROPE MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 35. FRANCE MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 36. FRANCE MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 37. FRANCE MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 38. GERMANY MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 39. GERMANY MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 40. GERMANY MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 41. ITALY MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 42. ITALY MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 43. ITALY MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 44. SPAIN MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 45. SPAIN MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 46. SPAIN MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 47. UK MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 48. UK MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 49. UK MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 50. REST OF EUROPE MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 51. REST OF EUROPE MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 52. REST OF EUROPE MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 53. ASIA-PACIFIC MICROFLUIDICS MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 54. ASIA-PACIFIC MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 55. ASIA-PACIFIC MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 56. ASIA-PACIFIC MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 57. CHINA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 58. CHINA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 59. CHINA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 60. JAPAN MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 61. JAPAN MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 62. JAPAN MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 63. INDIA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 64. INDIA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 65. INDIA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 66. SOUTH KOREA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 67. SOUTH KOREA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 68. SOUTH KOREA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 69. AUSTRALIA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 70. AUSTRALIA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 71. AUSTRALIA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 72. REST OF ASIA-PACIFIC MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 73. REST OF ASIA-PACIFIC MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 74. REST OF ASIA-PACIFIC MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 75. LAMEA MICROFLUIDICS MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 76. LAMEA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 77. LAMEA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 78. LAMEA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 79. BRAZIL MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 80. BRAZIL MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 81. BRAZIL MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 82. SOUTH AFRICA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 83. SOUTH AFRICA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 84. SOUTH AFRICA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 85. SAUDI ARABIA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 86. SAUDI ARABIA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 87. SAUDI ARABIA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 88. UAE MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 89. UAE MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 90. UAE MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 91. REST OF LAMEA MICROFLUIDICS MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 92. REST OF LAMEA MICROFLUIDICS MARKET, BY MATERIAL, 2024 - 2033 ($MILLION); TABLE 93. REST OF LAMEA MICROFLUIDICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($MILLION); TABLE 94. ILLUMINA, INC.: KEY EXECUTIVES; TABLE 95. ILLUMINA, INC.: COMPANY SNAPSHOT; TABLE 96. ILLUMINA, INC.: OPERATING SEGMENTS; TABLE 97. ILLUMINA, INC.: PRODUCT PORTFOLIO; TABLE 98. ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 99. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES; TABLE 100. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT; TABLE 101. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS; TABLE 102. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO; TABLE 103. BIO-RAD LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 104. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES; TABLE 105. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT; TABLE 106. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS; TABLE 107. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO; TABLE 108. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 109. PERKINELMER, INC.: KEY EXECUTIVES; TABLE 110. PERKINELMER, INC.: COMPANY SNAPSHOT; TABLE 111. PERKINELMER, INC.: OPERATING SEGMENTS; TABLE 112. PERKINELMER, INC.: PRODUCT PORTFOLIO; TABLE 113. PERKINELMER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 114. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES; TABLE 115. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT; TABLE 116. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS; TABLE 117. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO; TABLE 118. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 119. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES; TABLE 120. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT; TABLE 121. AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS; TABLE 122. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO; TABLE 123. AGILENT TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 124. STANDARD BIOTOOLS: KEY EXECUTIVES; TABLE 125. STANDARD BIOTOOLS: COMPANY SNAPSHOT; TABLE 126. STANDARD BIOTOOLS: OPERATING SEGMENTS; TABLE 127. STANDARD BIOTOOLS: PRODUCT PORTFOLIO; TABLE 128. STANDARD BIOTOOLS: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 129. DANAHER CORPORATION: KEY EXECUTIVES; TABLE 130. DANAHER CORPORATION: COMPANY SNAPSHOT; TABLE 131. DANAHER CORPORATION: OPERATING SEGMENTS; TABLE 132. DANAHER CORPORATION: PRODUCT PORTFOLIO; TABLE 133. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 134. ABBOTT: KEY EXECUTIVES; TABLE 135. ABBOTT: COMPANY SNAPSHOT; TABLE 136. ABBOTT: OPERATING SEGMENTS; TABLE 137. ABBOTT: PRODUCT PORTFOLIO; TABLE 138. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 139. BIOMERIEUX: KEY EXECUTIVES; TABLE 140. BIOMERIEUX: COMPANY SNAPSHOT; TABLE 141. BIOMERIEUX: OPERATING SEGMENTS; TABLE 142. BIOMERIEUX: PRODUCT PORTFOLIO; TABLE 143. BIOMERIEUX: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES: FIGURE 1. GLOBAL MICROFLUIDICS MARKET, 2024 - 2033; FIGURE 2. SEGMENTATION OF MICROFLUIDICS MARKET, 2024 - 2033; FIGURE 3. TOP INVESTMENT POCKET IN MICROFLUIDICS MARKET; FIGURE 4. MODERATE BARGAINING POWER OF BUYERS; FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS; FIGURE 6. MODERATE THREAT OF NEW ENTRANTS; FIGURE 7. LOW THREAT OF SUBSTITUTION; FIGURE 8. HIGH COMPETITIVE RIVALRY; FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMICROFLUIDICS MARKET; FIGURE 10. GLOBAL MICROFLUIDICS MARKET SEGMENTATION, BY APPLICATION; FIGURE 11. MICROFLUIDICS MARKET FOR MEDICAL/HEALTHCARE, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 12. MICROFLUIDICS MARKET FOR NON-MEDICAL, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 13. GLOBAL MICROFLUIDICS MARKET SEGMENTATION, BY MATERIAL; FIGURE 14. MICROFLUIDICS MARKET FOR SILICONE, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 15. MICROFLUIDICS MARKET FOR GLASS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 16. MICROFLUIDICS MARKET FOR POLYMER, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 17. MICROFLUIDICS MARKET FOR PDMS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 18. MICROFLUIDICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 19. GLOBAL MICROFLUIDICS MARKET SEGMENTATION, BY TECHNOLOGY; FIGURE 20. MICROFLUIDICS MARKET FOR LAB-ON-A-CHIP, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 21. MICROFLUIDICS MARKET FOR ORGANS-ON-CHIPS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 22. MICROFLUIDICS MARKET FOR CONTINUOUS FLOW MICROFLUIDICS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 23. MICROFLUIDICS MARKET FOR OPTOFLUIDICS MICROFLUIDICS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 24. MICROFLUIDICS MARKET FOR ACOUSTOFLUIDICS MICROFLUIDICS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 25. MICROFLUIDICS MARKET FOR ELECTROPHORESIS MICROFLUIDICS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*; FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*; FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*; FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 30. COMPETITIVE DASHBOARD; FIGURE 31. COMPETITIVE HEATMAP: MICROFLUIDICS MARKET; FIGURE 32. TOP PLAYER POSITIONING, 2023; FIGURE 33. ILLUMINA, INC.: NET SALES, 2021-2023 ($MILLION); FIGURE 34. ILLUMINA, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 35. ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 36. BIO-RAD LABORATORIES, INC.: NET SALES, 2021-2023 ($MILLION); FIGURE 37. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 38. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 39. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($MILLION); FIGURE 40. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 41. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 42. PERKINELMER, INC.: NET SALES, 2021-2023 ($MILLION); FIGURE 43. PERKINELMER, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 44. PERKINELMER, INC.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 45. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2021-2023 ($MILLION); FIGURE 46. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 47. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 48. AGILENT TECHNOLOGIES, INC.: NET SALES, 2021-2023 ($MILLION); FIGURE 49. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 50. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 51. STANDARD BIOTOOLS: NET SALES, 2021-2023 ($MILLION); FIGURE 52. STANDARD BIOTOOLS: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 53. STANDARD BIOTOOLS: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 54. DANAHER CORPORATION: NET SALES, 2021-2023 ($MILLION); FIGURE 55. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 56. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 57. ABBOTT: NET SALES, 2021-2023 ($MILLION); FIGURE 58. ABBOTT: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 59. ABBOTT: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 60. BIOMERIEUX: NET SALES, 2021-2023 ($MILLION); FIGURE 61. BIOMERIEUX: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 62. BIOMERIEUX: REVENUE SHARE, BY REGION, 2023 (%)